We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current OVID market cap is 216.37M. The company's latest EPS is USD -0.7402 and P/E is -4.13.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 11k | 47k | 66k | 75k | 109k |
| Operating Income | -12.8M | -12.17M | -14.89M | -14.17M | -12.03M |
| Net Income | -11.97M | -11.51M | -13.36M | -12.41M | -11.25M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 12.62M | 208.38M | 1.5M | 392k |
| Operating Income | -61.41M | -81.43M | 124.21M | -55.55M | -59.28M |
| Net Income | -60.46M | -81.04M | 122.84M | -54.17M | -52.34M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 165.03M | 155.27M | 143.37M | 136.23M | 125.03M |
| Total Liabilities | 22.98M | 22.99M | 22.42M | 25.53M | 23.74M |
| Total Equity | 142.05M | 132.27M | 120.95M | 110.7M | 101.29M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 80.84M | 75.93M | 194.55M | 155.27M | 144.03M |
| Total Liabilities | 10.82M | 32.29M | 14.8M | 22.99M | 56.23M |
| Total Equity | 70.02M | 43.63M | 179.75M | 132.27M | 87.8M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -46.05M | -55.23M | -12.11M | -23.82M | -33.87M |
| Investing | -83.71M | -87.88M | 30.23M | 50.3M | 45.94M |
| Financing | 224k | 181k | 67k | 278k | 502k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -51.09M | -51.58M | 118.61M | -55.23M | -45.78M |
| Investing | -30.04M | 34.65M | -1.82M | -87.88M | -2.58M |
| Financing | 86.54M | 47.07M | 903k | 181k | 30.54M |
| Market Cap | 216.37M |
| Price to Earnings Ratio | -4.13 |
| Price to Sales Ratio | 556.36 |
| Price to Cash Ratio | 8 |
| Price to Book Ratio | 2.46 |
| Dividend Yield | - |
| Shares Outstanding | 70.71M |
| Average Volume (1 week) | 184.22k |
| Average Volume (1 Month) | 149.87k |
| 52 Week Change | -15.00% |
| 52 Week High | 4.1389 |
| 52 Week Low | 2.57 |
| Spread (Intraday) | 0.35 (10.45%) |
| Company Name | Ovid Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://ovidrx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
